Brief: Goldman Sachs Group's Long Position In Shanghai Heartcare Medical Tech Rises To 5.1% - HKEX Filing

Shanghai HeartCare Medical Technology

09/09/2021 10:14

Sept 9 (Reuters) - Hong Kong stock exchange filing:
    * GOLDMAN SACHS GROUP INC BOUGHT 49,650 SHARES IN SHANGHAI
HEARTCARE MEDICAL TECHNOLOGY  6609.HK  AT AVG PRICE OF HK$142.63
 ($18.34) PER SHARE ON SEPT 6 - HKEX FILING
    * GOLDMAN SACHS GROUP INC'S LONG POSITION IN SHANGHAI
HEARTCARE
MEDICAL TECHNOLOGY RISES TO 5.10% FROM 4.95% - HKEX FILING

Source text https://di.hkex.com.hk/di/NSForm2.aspx?fn=CS20210909E00074&sa2=ns&sid=353908&sd=09/09/2020&ed=09/09/2021&sa1=cl&scsd=09/09/2020&sced=09/09/2021&sc=06609&src=Main&lang=EN&tk=ds
Further company coverage:  6609.HK 

($1 = 7.7766 Hong Kong dollars)

 (Reporting by Hong Kong newsroom)
 ((twinnie.siu@tr.com; 852-3462 7715;))